Healthcare Press

HSE decision on muscular disease drug 'not a final no'

  • 📰 rtenews
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 99%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

HSE informed patients last week that it would not sanction use of the drug because of the cost involved

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Put our taxes into saving lives SimonHarrisTD roinnslainte not ending them? prolifecampaign

The solution is simple make cannabis legal it has been proven for a fact to help in this area

Yet they waste money on water meters, electronic voting machines, business class flights for unelected wives...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Drug for children with spinal muscular atrophy too expensive, HSE saysHealth body says providing Spinraza would cost some €600,000 per patient in first year Children Hospital at €1.7bn NGO funding of €5bn Overseas Aid DP Refugee Racket All Ok KylaHollywood have you seen this?
Source: IrishTimes - 🏆 3. / 98 Read more »